Skip to main content
Equibles
AYTU logo

AYTU · Aytu Biopharma, Inc · Short Interest

Track AYTU — free

Use AYTU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AYTU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.93 +0.03 (+1.58%) At close · Oct 26
Rebalance outlook locked
Market Cap
$20.97M
Shares
10.87M
Volume · Oct 26 16.56K Avg daily vol (3M) 34.93K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

AYTU Latest Reported Short Interest

FINRA reported 328,872 AYTU shares sold short as of the October 15, 2026 settlement date, a decrease of 16,357 shares. Days to cover was 13.96 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

AYTU Short Interest Forecast

Equibles' model estimates 327,983 shares sold short for the October 30, 2026 settlement, -0.3% versus the latest reported position, with a likely range of 287,526 to 364,067 shares. This model prediction uses FINRA data through October 16, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 16 Low confidence 62% chance it falls
327,983 -0.3% vs reported
Likely range 287,526 to 364,067 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
64/100
Short interest 3.0% of shares — P57 Days to cover 14.0 — P95 Price vs VWAP -12.0% — P36 Short-volume trend +5.6% — P73 Short interest change -4.7% — P33 Worst FTD 0.11% of shares — P85

Positioning score 64.1 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-27 03:32 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-11-13 Scheduled
    FINRA publishes Nov 24
    		 — — — —
    2026-10-30 Scheduled
    FINRA publishes Nov 10
    		 — — — —
    2026-10-15 328,872 345,229 -16,357 13.96
    2026-09-30 345,229 311,607 +33,622 4.74
    2026-09-15 311,607 334,399 -22,792 12.88
    2026-08-31 334,399 321,535 +12,864 12.35
    2026-08-14 321,535 326,227 -4,692 9.77
    2026-07-31 326,227 347,011 -20,784 12.49
    2026-07-15 347,011 348,497 -1,486 15.78
    2026-06-30 348,497 354,360 -5,863 11.96
    2026-06-15 354,360 407,982 -53,622 12.17
    2026-05-29 407,982 457,791 -49,809 8.71
    2026-05-15 457,791 505,368 -47,577 7.14
    2026-04-30 505,368 502,212 +3,156 19.74
    2026-04-15 502,212 503,361 -1,149 13.60
    2026-03-31 503,361 507,879 -4,518 9.93
    2026-03-13 507,879 471,283 +36,596 11.66
    2026-02-27 471,283 453,509 +17,774 11.87
    2026-02-13 453,509 548,197 -94,688 5.80
    2026-01-30 548,197 542,708 +5,489 6.50
    2026-01-15 542,708 513,218 +29,490 3.31
    2025-12-31 513,218 462,866 +50,352 3.86
    2025-12-15 462,866 457,210 +5,656 7.99
    2025-11-28 457,210 487,373 -30,163 9.24
    2025-11-14 487,373 499,690 -12,317 7.75
    2025-10-31 499,690 612,597 -112,907 6.11

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1385818 CUSIP 054754858 13F (30d) 4 filings 4 filers Visit website Investor relations